PGIM Jennison Health Sciences Fund Q1 2025 Commentary
Source: SeekingAlpha
2025-06-12 10:10:00 ET
PERFORMANCE RECAP
The S&P 1500 Health Care Index (the Index) gained 0.9% in February, outperforming the S&P 500, which declined -1.3%. Biotechnology, health care technology, and pharmaceuticals outperformed the Index during the month. Meanwhile, life sciences tools & services, health care providers & services, and medical technology (medtech) lost ground during the month....
Read the full article on Seeking Alpha
For further details see:
PGIM Jennison Health Sciences Fund Q1 2025 Commentary
Vaxcyte Inc.
NASDAQ: PCVX
PCVX Trading
0.36% G/L:
$58.38 Last:
341,094 Volume:
$58 Open:
PCVX Latest News
February 24, 2026 04:05:00 pm
Vaxcyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 11, 2026 04:05:00 pm
Vaxcyte Doses First Participants in OPUS-3 Phase 3 Trial Evaluating VAX-31 in Adults Previously Vaccinated with Lower-Valency Pneumococcal Vaccines
February 10, 2026 04:05:00 pm
Vaxcyte to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on February 24, 2026
PCVX Stock Data
$7,801,730,421
136,657,209
0.01%
97
N/A
Biotechnology & Life Sciences
Healthcare
US
San Carlos
